Back
Nxera Pharma Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
SOLTF
Nxera Pharma
Last Price:
$5.91
Seasonality Move:
15.18%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.
Nxera Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.91 | Sell |
20-day SMA: | 5.91 | Sell |
50-day SMA: | 6.02 | Sell |
200-day SMA: | 7.37 | Sell |
8-day EMA: | 5.91 | Sell |
20-day EMA: | 5.92 | Sell |
50-day EMA: | 6.05 | Sell |
200-day EMA: | 7.23 | Sell |
Nxera Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 1.68 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.91 - 5.91) | Sell |
Bollinger Bands (100): | (5.95 - 6.53) | Sell |
Nxera Pharma Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Nxera Pharma Stock
Is Nxera Pharma Stock a Buy?
-
Nxera Pharma share price is 5.91 while SOLTF 8-day simple moving average is 5.91, which is a Sell signal.
-
The stock price of SOLTF is 5.91 while Nxera Pharma 20-day SMA is 5.91, which makes it a Sell.
-
Nxera Pharma 50-day simple moving average is 6.02 while SOLTF share price is 5.91, making it a Sell technically.
-
SOLTF stock price is 5.91 and Nxera Pharma 200-day simple moving average is 7.37, creating a Sell signal.
SOLTF Technical Analysis vs Fundamental Analysis
Sell
27
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy or a Sell?
-
Nxera Pharma stock is rated a SellThe current Nxera Pharma [SOLTF] share price is $5.91. The Score for SOLTF is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Nxera Pharma Stock Info
Market Cap:
531.3M
Price in USD:
5.91
Share Volume:
0
Nxera Pharma 52-Week Range
52-Week High:
10.67
52-Week Low:
5.54
Sell
27
Nxera Pharma (SOLTF)
is a Sell
Nxera Pharma Share Price Forecast
-
What is the Nxera Pharma stock price today?The Nxera Pharma stock price is 5.91 USD today.
-
Will SOLTF stock go up or go down?Nxera Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Nxera Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nxera Pharma is overvalued.
Is Nxera Pharma Stock a Buy?
-
Nxera Pharma share price is 5.91 while SOLTF 8-day exponential moving average is 5.91, which is a Sell signal.
-
The stock price of SOLTF is 5.91 while Nxera Pharma 20-day EMA is 5.92, which makes it a Sell.
-
Nxera Pharma 50-day exponential moving average is 6.05 while SOLTF share price is 5.91, making it a Sell technically.
-
SOLTF stock price is 5.91 and Nxera Pharma 200-day simple moving average is 7.23, creating a Sell signal.
Technical Analysis of Nxera Pharma
Should I short Nxera Pharma stock?
-
SOLTF Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Nxera Pharma is a Sell
-
Nxera Pharma Relative Strength Index (RSI) is 1.68, which suggest Nxera Pharma is oversold
-
The Bollinger Bands (25) for Nxera Pharma is (5.91 - 5.91), which suggest Nxera Pharma is a Sell
-
The Bollinger Bands (100) for Nxera Pharma is (5.95 - 6.53), which suggest Nxera Pharma is a Sell
* Nxera Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.